Theravance Biopharma announces Viatris receives China NMPA approval for Yupelri inhalation solution to treat COPD: Dublin Friday, June 27, 2025, 17:00 Hrs [IST] Theravance Biophar ...

Theravance Biopharma’s partner Viatris has received China's NMPA approval for Yupelri inhalation solution for maintenance treatment of COPD.

The Institute has a strong pedigree in understanding the fundamental mechanisms that underpin the success of vaccination and in the development of novel vaccines and their mode of action.